A guide to informed and responsible psychedelic use
• Draws on current research, interviews, and case studies to detail the risks and benefits of psychedelics like LSD, psilocybin, MDMA, ketamine, and mescaline
• Explores the short- and long-term effects of psychedelics, looking at heart rate, blood pressure, and markers of mental health
• Includes in-depth profiles of psychedelics, considering their chemical composition, effects, safety considerations, and legal status
The psychedelic renaissance has been opening new therapeutic modalities in Western medicine. With the potential to reduce our reliance on pharmaceuticals and improve overall well-being, the use of psychedelics has yielded promising results. However, the increased acceptance and use of these age-old medicines should also be approached with caution and full awareness.
Clinical psychologist Richard Louis Miller provides a balanced analysis of the risks and benefits of psychedelics to ensure their responsible use. He comprehensively details the rewards and potential complications of substances like LSD, psilocybin, ayahuasca, DMT, MDMA, and ketamine to provide thorough risk profiles and a working guide for psychedelic-informed therapy.
Drawing on the latest research, interviews with practitioners, and case studies, Dr. Miller considers physiological effects like nausea, altered heart rate, and blood pressure changes, along with mental effects such as anxiety, reality distortion, and mood disorders often associated with a bad trip. He also includes an extensive, in-depth Psychedelic Clinical Profiles guide to the 13 most commonly used psychedelic substances, detailing their chemical composition, safety considerations, and legal status.
As psychedelics become more accepted as medicines, it is important that we become fully knowledgeable about their effects. By revealing the benefits and risks, this book is a key resource in the ethical and responsible use of psychedelics.
Inhaltsverzeichnis
PROLOGUE The Space Between Hope and Caution,
Promise and Peril
PART 1
The Promises and Pitfalls of the
Psychedelic Renaissance
ONE Full Transparency
TWO Understanding Psychedelic Substances
PART 2
Acute Adverse Effects
THREE Mental Adverse Effects
FOUR Somatic Challenges
PART 3
Prolonged Adverse Effects
FIVE Prolonged Perceptual Changes
SIX Long-Term Psychological and
Existential Disturbances
SEVEN The Enigma of Recovered Memories
PART 4
The Crucial Need for
Professional Standards
EIGHT Abuse of Patient Trust in Psychedelic Therapy
NINE Ramifications of an Unsafe Environment
TEN Harm Reduction—From Theory to Practice
ELEVEN Integration
TWELVE The Way Forward
Resources for Psychedelic Safety, Research,
and Integration
Guide to Psychedelic Clinical Profiles
2C-B (2,5-dimethoxy-4-bromophenethylamine)
5-APB (5-(2-Aminopropyl)benzofuran)
5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine)
Ayahuasca
DMT (N,N-Dimethyltryptamine)
DOM (2,5-Dimethoxy-4-methylamphetamine)
Ibogaine
Ketamine (2-(2-chlorophenyl)-2-(methylamino)
cyclohexanone)
LSD (Lysergic Acid Diethylamide)
MDMA (3,4-Methylenedioxymethamphetamine)
Mescaline (3,4,5-trimethoxyphenethylamine)
Psilocybin Mushrooms
Salvia divinorum / Salvinorin A
References
Index
